Abstract
Objective
A meta-analysis was conducted to evaluate the association of PTPN22 gene (+1858C/T −1123G/C) polymorphism with T1DM susceptibility.
Methods
Electronic databases were used to identify published studies before September 2011.
We adopted the most appropriate genetic model. The combined odds ratio (OR) with 95%
confidence interval (95% CI) was calculated to estimate the strength of the association
in a fixed or random effect model. Heterogeneity and publication bias were also assessed.
Results
Totally, 25 case–control studies including 8613 T1DM cases and 10,133 healthy controls
(24 studies containing 8129 cases and 9641 controls for PTPN22 +1858C/T, 5 studies including 1460 cases and 1609 controls for PTPN22 −1123G/C) were identified as eligible and analyzed. The most appropriate co-dominant
model was adopted. A significant association of PTPN22 +1858C/T gene polymorphism was found in overall population. When stratified by race,
significance was observed in Europe and America, but not in Asia. We did not detect
any association for PTPN22 −1123G/C polymorphism.
Conclusions
Our study indicated that T1DM is associated with PTPN22 +1858C/T gene polymorphism, and targeting this promoter polymorphism should be dependent
on ethnicity. Whether −1123G/C polymorphism is a susceptibility locus for T1DM, further
studies with well-designed among different ethnicity populations are required.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Autoimmune type 1 diabetes: resolved and unresolved.J Clin Invest. 2001; 108: 1247-1252
- Genetic epidemiology of type 1 diabetes.Pediatr Diabetes. 2003; 4: 87-100
- HL-A antigens and diabetes mellitus.Lancet. 1974; 2: 864-866
- A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus.Diabetes. 1984; 33: 176-183
- CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity?.Genes Immun. 2000; 1: 170-184
- A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families.Genes Immun. 2004; 5: 678-680
- Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.J Exp Med. 1999; 189: 111-121
- The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes.Diabetologia. 2001; 44: 914-922
- Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.Arthritis Rheum. 2005; 52: 1993-1998
- Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.Arthritis Rheum. 2005; 52: 219-224
- Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves’ disease in a Polish population: association and gene dose-dependent correlation with age of onset.Clin Endocrinol (Oxf). 2005; 62: 679-682
- PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits.Diabetes. 2007; 56: 522-526
- PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients.Int J Immunogenet. 2010; 37: 367-372
- No independent role of the −1123 G>C and +2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations.Diabetes Res Clin Pract. 2007; 76: 297-303
- The −1123G>C variant of PTPN22 gene promoter is associated with latent autoimmune diabetes in adult Chinese Hans.Cell Biochem Biophys. 2011;
- Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations.Am J Med Genet A. 2006; 140: 586-593
- Association between the 1858T allele of the protein tyrosine phosphatase nonreceptor type 22 and type 1 diabetes in a Brazilian population.Tissue Antigens. 2010; 76: 144-148
- Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves’ disease but not with rheumatoid arthritis in Russian population.Aging (Albany NY). 2011; 3: 368-373
- Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians.Diabetes Res Clin Pract. 2009; 86: 54-57
- Association of the C1858T polymorphism of the PTPN22 gene with type 1 diabetes.Mol Biol (Mosk). 2009; 43: 1040-1043
- Association of the PTPN22/LYP gene with type 1 diabetes.Pediatr Diabetes. 2006; 7: 274-278
- Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes.Diabetes. 2005; 54: 906-908
- No evidence for association of PTPN22 R620W functional variant C1858T with type 1 diabetes in Asian Indians.J Cell Mol Med. 2008 Jun; 12: 1061-1062
- Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population.Tissue Antigens. 2008; 72: 425-430
- PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases.Genes Immun. 2005; 6: 628-631
- Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus.Diabetes. 2004; 53: 3020-3023
- Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.BMC Med Genet. 2007; 13: 54
- The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population.Tissue Antigens. 2006 May; 67: 430-433
- The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.Thyroid. 2009; 19: 143-148
- Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population.Eur J Endocrinol. 2005; 153: 895-899
- Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population.Genes Immun. 2005; 6: 459-461
- A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.Nat Genet. 2004; 36: 337-338
- The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.Diabetes Care. 2008; 31: 534-538
- PTPN22 1858T allele is associated with younger age at onset of type 1 diabetes and is not related to subsequent thyroid autoimmunity.Hum Immunol. 2010; 71: 731-732
- Performing the exact test of Hardy–Weinberg proportion for multiple alleles.Biometrics. 1992; 48: 361-372
- Hardy–Weinberg equilibrium test and allele frequency estimation.Stata Tech Bull. 1999; 48: 34-37
- Hardy–Weinberg equilibrium test in case–control studies.Stata Tech Bull. 2000; 57: 17-19
- A method for meta-analysis of molecular association studies.Stat Med. 2005; 24: 1291-1306
- Operating characteristics of a rank correlation test for publication bias.Biometrics. 1994; 50: 1088-1101
- Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997; 315: 629-634
- ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case–control studies.Prostate Cancer Prostatic Dis. 2010; 13: 270-277
- The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis.Rheumatology. 2007; 46: 49-56
Article info
Publication history
Published online: May 09, 2012
Accepted:
April 16,
2012
Received in revised form:
February 28,
2012
Received:
November 28,
2011
Identification
Copyright
© 2012 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.
